LUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong

Stock News

01/27

Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake. LUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million. Following the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1141447932"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1141447932\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1141447932?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-27 08:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1141447932","market":"sh","top_or_hot":-1,"title":"LUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong","media":"Stock News","content":"<p>Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake.\nLUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million.\nFollowing the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLUYE PHARMA (02186) Shareholder Transfers HK$454 Million Worth of Shares from CCB International Securities to UBS Securities Hong Kong\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-27 08:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake.\nLUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million.\nFollowing the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1606","symbol_name":"中医药概念","start_time":0,"source_url":"","article_id":"1141447932","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1141447932","pubTimestamp":1769475499,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"161027":"证券","BK1606":"中医药概念","BK1583":"高瓴概念","02186":"绿叶制药","BK1191":"制药"},"translate_title":"绿叶制药(02186)股东向瑞银证券香港转让建银国际证券价值4.54亿港元股份","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161027":1,"02186":1},"content_text":"Hong Kong stock exchange data reveals that on January 26, a shareholder of LUYE PHARMA (02186) transferred shares from CCB International Securities to UBS Securities Hong Kong Limited. The transferred shares had a market value of HK$454 million, representing a 3.88% stake.\nLUYE PHARMA announced that on January 26, 2026, Shenzhen Luye, Nanjing Xinshi, Nanjing Xin'an, Ningbo Xinda, and Nanjing Luye entered into a capital injection agreement. Under this agreement, Nanjing Xin'an and Ningbo Xinda agreed to provide Nanjing Luye with additional capital totaling RMB 285 million.\nFollowing the completion of the capital injection, Nanjing Luye will be 70.01% owned by Shenzhen Luye, 23.34% by Nanjing Xinshi, 4.32% by Nanjing Xin'an, and 2.33% by Ningbo Xinda.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}